{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:36:47Z","timestamp":1763059007547,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ad.2023.10.030","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T15:13:34Z","timestamp":1699024414000},"page":"T10-T20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["[Translated article] Family Planning Concerns Among Women With Psoriasis: A Descriptive, Cross-Sectional, Multicenter Study"],"prefix":"10.1016","volume":"115","author":[{"given":"N.","family":"Jim\u00e9nez G\u00f3mez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"Gonz\u00e1lez-Cantero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ruiz-Villaverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Llamas-Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"de la Cueva Dobao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rivera D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mart\u00ednez Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.","family":"Alonso Pacheco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Baniandr\u00e9s Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Mollet S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pitarch Bort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Izu Belloso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ja\u00e9n Olasolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2023.10.030_bib0115","unstructured":"World Health Organization. Global report on psoriasis [Internet]. Geneva: World Health Organization; 2016, [accessed Mar 5 2022]. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/204417."},{"key":"10.1016\/j.ad.2023.10.030_bib0120","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ad.2013.12.008","article-title":"Prevalence of psoriasis in Spain in the age of biologics","volume":"105","author":"Ferr\u00e1ndiz","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2023.10.030_bib0125","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.7573\/dic.2019-11-6","article-title":"Management of psoriasis in pregnancy - a review of the evidence to date","volume":"9","author":"Ferreira","year":"2020","journal-title":"Drugs Context."},{"key":"10.1016\/j.ad.2023.10.030_bib0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijwd.2016.12.003","article-title":"Update on biologic safety for patients with psoriasis during pregnancy","volume":"3","author":"Porter","year":"2017","journal-title":"Int J Womens Dermatol."},{"key":"10.1016\/j.ad.2023.10.030_bib0135","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijwd.2019.04.021","article-title":"Clinical considerations for the management of psoriasis in women","volume":"5","author":"Gottlieb","year":"2019","journal-title":"Int J Womens Dermatol."},{"key":"10.1016\/j.ad.2023.10.030_bib0140","doi-asserted-by":"crossref","first-page":"AB65","DOI":"10.1016\/j.jaad.2019.06.265","article-title":"Fears and misconceptions of women with chronic inflammatory diseases on their journey to motherhood","volume":"81","author":"Murase","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2023.10.030_bib0145","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/bjd.18164","article-title":"Women with moderate to-severe psoriasis in Spain (BIOBADADERM registry) show more than a 50% reduction in age-adjusted fertility rate when compared with the general population","volume":"181","author":"Gonzalez-Cantero","year":"2019","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2023.10.030_bib0150","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1111\/jdv.17737","article-title":"Women with moderate-to-severe psoriasis in Spain (BIOBADADERM registry) breastfeed less when compared with general population","volume":"36","author":"Rivera-Diaz","year":"2022","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2023.10.030_bib0155","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archderm.141.5.601","article-title":"Hormonal effect on psoriasis in pregnancy and post partum","volume":"141","author":"Murase","year":"2005","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.ad.2023.10.030_bib0160","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bjd.14547","article-title":"Psoriasis and adverse pregnancy outcomes: a systematic review of observational studies","volume":"175","author":"Bobotsis","year":"2016","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2023.10.030_bib0165","first-page":"183","article-title":"Pregnancy outcome in women with psoriasis","volume":"53","author":"Ben-David","year":"2008","journal-title":"J Reprod Med."},{"key":"10.1016\/j.ad.2023.10.030_bib0170","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2340\/00015555-2923","article-title":"Effect of Maternal Psoriasis on Pregnancy and Birth Outcomes: A Population-based Cohort Study from Denmark and Sweden","volume":"98","author":"Br\u00f6ms","year":"2018","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2023.10.030_bib0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ad.2020.10.002","article-title":"Consenso sobre las actuaciones a seguir durante la edad f\u00e9rtil, el embarazo, el posparto y la lactancia en pacientes con psoriasis","volume":"112","author":"Belinch\u00f3n","year":"2021","journal-title":"Actas Dermosifiliogr."},{"year":"2022","series-title":"Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk","author":"Briggs","key":"10.1016\/j.ad.2023.10.030_bib0180"},{"key":"10.1016\/j.ad.2023.10.030_bib0185","doi-asserted-by":"crossref","first-page":"401.e1","DOI":"10.1016\/j.jaad.2013.09.010","article-title":"Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy","volume":"70","author":"Murase","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2023.10.030_bib0190","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/annrheumdis-2017-212196","article-title":"Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study","volume":"77","author":"Mariette","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ad.2023.10.030_bib0195","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1136\/annrheumdis-2017-211384","article-title":"Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study","volume":"76","author":"Clowse","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ad.2023.10.030_bib0200","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Certolizumab, [accessed 9 Sep 2022]. Available from: https:\/\/cima.aemps.es\/cima\/publico\/lista.html."},{"key":"10.1016\/j.ad.2023.10.030_bib0205","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.ad.2023.10.030_bib0210","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jri.2016.04.284","article-title":"Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer","volume":"116","author":"Porter","year":"2016","journal-title":"J Reprod Immunol."},{"key":"10.1016\/j.ad.2023.10.030_bib0215","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/jan.13007","article-title":"Risk perception in pregnancy: a concept analysis","volume":"72","author":"Lennon","year":"2016","journal-title":"J Adv Nurs."},{"key":"10.1016\/j.ad.2023.10.030_bib0220","doi-asserted-by":"crossref","first-page":"e0254956","DOI":"10.1371\/journal.pone.0254956","article-title":"Perceptions of risk in pregnancy with chronic disease: A systematic review and thematic synthesis","volume":"16","author":"Ralston","year":"2021","journal-title":"Plos One."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731023008633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731023008633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:17:31Z","timestamp":1757553451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731023008633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0001731023008633"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2023.10.030","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Family Planning Concerns Among Women With Psoriasis: A Descriptive, Cross-Sectional, Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2023.10.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2023.06.015","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}